Strategic partnerships Medichem is expanding its U.S. presence through new license and supply agreements with Somerset Therapeutics, signaling growth opportunities for contract manufacturing, API supply, and finished dosage form collaborations in the U.S. market.

Global footprint With operations and teams across the USA, Malta, China, and Spain, Medichem serves over 600 corporate clients in more than 60 countries, indicating strong international distribution and potential for cross-border API and FDF opportunities, including chlorhexidine products where they are a world leader.

Sustainability lead Awarded COASHIQ Sustainability Award for Waste, Water and Climate Change Management Programs enhances credibility with sustainability-focused buyers and policy-driven health organizations seeking environmentally responsible manufacturing partners.

Vertical integration As a vertically integrated provider offering both APIs and Finished Dosage Forms plus R&D, contract manufacturing, and licensing, Medichem can meet end-to-end sourcing needs, presenting upsell opportunities for existing clients and new entrants in the generics market.

Strategic collaborations Recent strategic collaboration with Breckenridge Pharmaceutical to develop injectable hospital products and manufacturing in Spain creates a partner-ready pathway for hospital-formulations and sterile product cases, expanding Medichem’s portfolio into high-value dosage forms.